Guidance for Administering Biologics for Severe Asthma and Allergic Conditions.
Ontology highlight
ABSTRACT: Asthma is a common respiratory disorder in Canada for which biologics may be prescribed for poorly controlled illness. Treatment with biologics, however, is sometimes inappropriately discontinued due to misconceptions regarding their potential immunologic effects, and concerns surrounding their continued use in severe asthma during the COVID-19 pandemic continue to propagate. Biologics can still be administered in a majority of health and treatment conditions. With regard to cardiac-related issues such as hypertension or cardiovascular disease (CVD), there is no solid evidence that suggests biologics should be withheld, as the benefits of treatment outweigh the risks. Asthmatic patients on biologic treatment should also continue treatment if they have, or are currently being treated for, a
SUBMITTER: Dorscheid DR
PROVIDER: S-EPMC9482537 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA